Cargando…

Zeta Inhibitory Peptide as a Novel Therapy to Control Chronic Visceral Hypersensitivity in a Rat Model

BACKGROUND: The pathogenesis of multiple chronic visceral pain syndromes, such as irritable bowel syndrome (IBS), is not well known, and as a result current therapies are ineffective. The objective of this study was to investigate the effect of spinal protein kinase M zeta (PKMζ) on visceral pain se...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ying, Chen, Aiqin, Chen, Yu, Guo, Lixia, Dai, Hengfen, Huang, Yang, Chen, Qianqian, Lin, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077089/
https://www.ncbi.nlm.nih.gov/pubmed/27776136
http://dx.doi.org/10.1371/journal.pone.0163324